Correlation between HDL2, HDL3 and serum ferritin levels with fatty liver and NAFLD activity score (NAS) in liver histology of organ donors
- PMID: 34706656
- PMCID: PMC8549218
- DOI: 10.1186/s12876-021-01958-4
Correlation between HDL2, HDL3 and serum ferritin levels with fatty liver and NAFLD activity score (NAS) in liver histology of organ donors
Abstract
Background: Nonalcoholic fatty liver disease (NAFLD) is one of the most important liver diseases. High-density lipoprotein (HDL) has anti-atherogenic properties and its reduction can be associated with fatty liver. Serum ferritin levels are usually elevated in patients with NAFLD. This study aimed to evaluate the correlation between HDL subtypes and serum ferritin levels with evidence of NAFLD in liver histology of organ donors.
Methods: One hundred organ donor patients who were eligible for the study were included in the study and ferritin; HDL2 and HDL3 were measured in blood samples. Donated liver tissue biopsy specimens were evaluated for fatty liver and NAFLD activity score (NAS). In addition, AST and ALT were measured in recipients 24 h after transplant. All data abstracted and analyzed statistically.
Results: Serum HDL2 levels and HDL2/HDL3 ratio in patients with NAS > 1 were significantly lower (P < 0.05). Serum levels of HDL3 and ferritin were not significantly associated with NAS >1 (P > 0.05). In addition, serum ferritin > 1000 ng/ml in organ donors associated with increased AST and ALT levels 24 h after transplantation in the liver organ recipient.
Conclusions: Lower HDL2 values and HDL2/HDL3 ratio were associated with increased NAFLD activity score, but HDL3 and ferritin did not show such a relationship. In addition, higher levels of ferritin in organ donors may be associated with increased AST and ALT 24 h after liver transplantation in the organ recipient.
Keywords: Ferritin; High-density lipoprotein; Liver transplant; Nonalcoholic fatty liver disease.
© 2021. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Similar articles
-
Featured Article: Depletion of HDL3 high density lipoprotein and altered functionality of HDL2 in blood from sickle cell patients.Exp Biol Med (Maywood). 2017 Jun;242(12):1244-1253. doi: 10.1177/1535370217706966. Epub 2017 Apr 24. Exp Biol Med (Maywood). 2017. PMID: 28436274 Free PMC article.
-
Clinical-epidemiological analysis of HDL2 and HDL3 subfractions in adults from Maracaibo city, Venezuela.Rev Peru Med Exp Salud Publica. 2020 Dec 2;37(3):412-422. doi: 10.17843/rpmesp.2020.373.4787. Rev Peru Med Exp Salud Publica. 2020. PMID: 33295542 English, Spanish.
-
A dual-precipitation method evaluated for measurement of cholesterol in high-density lipoprotein subfractions HDL2 and HDL3 in human plasma.Clin Chem. 1989 Feb;35(2):265-70. Clin Chem. 1989. PMID: 2914371
-
High-density lipoprotein subclasses and their relationship to cardiovascular disease.J Clin Lipidol. 2012 Nov-Dec;6(6):496-523. doi: 10.1016/j.jacl.2012.03.001. Epub 2012 Mar 23. J Clin Lipidol. 2012. PMID: 23312047 Review.
-
Serum Ferritin and Non-alcoholic Fatty Liver Disease: A Meta-analysis and Systematic Review.Turk J Gastroenterol. 2023 Sep;34(9):952-960. doi: 10.5152/tjg.2023.22453. Turk J Gastroenterol. 2023. PMID: 37674440 Free PMC article.
Cited by
-
Gut microbiome in metabolic dysfunction-associated steatotic liver disease and associated hepatocellular carcinoma.Nat Rev Gastroenterol Hepatol. 2025 Sep;22(9):619-638. doi: 10.1038/s41575-025-01089-1. Epub 2025 Jul 7. Nat Rev Gastroenterol Hepatol. 2025. PMID: 40624229 Review.
-
Antiferroptosis therapy alleviated the development of atherosclerosis.MedComm (2020). 2024 Apr 4;5(4):e520. doi: 10.1002/mco2.520. eCollection 2024 Apr. MedComm (2020). 2024. PMID: 38576455 Free PMC article.
-
High-density lipoproteins and non-alcoholic fatty liver disease.Atheroscler Plus. 2023 Aug 19;53:33-41. doi: 10.1016/j.athplu.2023.08.001. eCollection 2023 Sep. Atheroscler Plus. 2023. PMID: 37663008 Free PMC article.
References
-
- Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, Landt CL, Harrison SA. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology. 2011;140(1):124–131. doi: 10.1053/j.gastro.2010.09.038. - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical